NYMOX PHARMACEUTICAL CORP's ticker is NYMX and the CUSIP is P73398102. A total of 38 filers reported holding NYMOX PHARMACEUTICAL CORP in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $1,000 | -66.7% | 2,500 | 0.0% | 0.00% | -100.0% |
Q1 2022 | $3,000 | 0.0% | 2,500 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $3,000 | -40.0% | 2,500 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $5,000 | +25.0% | 2,500 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $4,000 | -33.3% | 2,500 | 0.0% | 0.00% | -50.0% |
Q1 2021 | $6,000 | 0.0% | 2,500 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $6,000 | 0.0% | 2,500 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $6,000 | -25.0% | 2,500 | 0.0% | 0.00% | -33.3% |
Q2 2020 | $8,000 | +60.0% | 2,500 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $5,000 | 0.0% | 2,500 | 0.0% | 0.00% | +50.0% |
Q4 2019 | $5,000 | 0.0% | 2,500 | 0.0% | 0.00% | -33.3% |
Q3 2019 | $5,000 | +25.0% | 2,500 | 0.0% | 0.00% | +50.0% |
Q2 2019 | $4,000 | -20.0% | 2,500 | 0.0% | 0.00% | -33.3% |
Q1 2019 | $5,000 | +66.7% | 2,500 | 0.0% | 0.00% | +50.0% |
Q4 2018 | $3,000 | -50.0% | 2,500 | 0.0% | 0.00% | -33.3% |
Q3 2018 | $6,000 | -25.0% | 2,500 | 0.0% | 0.00% | -40.0% |
Q2 2018 | $8,000 | -27.3% | 2,500 | 0.0% | 0.01% | -28.6% |
Q1 2018 | $11,000 | – | 2,500 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MARATHON CAPITAL MANAGEMENT | 55,000 | $179,000 | 0.09% |
WEDBUSH SECURITIES INC | 180,945 | $590,000 | 0.09% |
Brown Advisory Securities, LLC | 28,000 | $91,000 | 0.03% |
FNY Managed Accounts LLC | 8,000 | $26,080,000 | 0.02% |
FT Options LLC | 10,000 | $26,000 | 0.02% |
WEBSTER BANK, N. A. | 40,000 | $130,000 | 0.02% |
GSA CAPITAL PARTNERS LLP | 30,907 | $101,000 | 0.01% |
GOFEN & GLOSSBERG LLC /IL/ | 25,000 | $82,000 | 0.00% |
NATIONAL PLANNING CORP | 11,000 | $32,000 | 0.00% |
Virtu KCG Holdings LLC | 24,705 | $81,000 | 0.00% |